Skip to content
  • Start
  • News
  • Video
  • Podcast
  • Event
  • Premium
    • Premium Content
    • VC Database
    • Company Database
    • Soft Funding & Grants
    • Job Database
  • About BioStock
Log in Subscribe
Home / donanemab

donanemab

Alzinova's CSO: “We are now ready to take the next step”

Alzheimer's studies are calling for patients

The development of drugs to treat Alzheimer's is accelerating, with a record number of clinical trials underway. One problem...

Alzinova new data

A breakthrough in Alzheimer's drug development?

While Alzheimer's disease constitutes an increasingly...

BioStock

  • Start
  • News
  • Video
  • Podcast
  • Event
  • About BioStock
  • Privacy Policy
  • Terms and Conditions

Read BioStock's newsletter

Get industry news, company information and invitations to BioStock events directly in your inbox!

Val*
This field is used for validation purposes and should be left unchanged.
© 2025 Biostock